AI steps in to prevent nuclear medicine mishaps

NCT ID NCT07174089

Recruiting now Knowledge-focused Sponsor: Azienda USL Reggio Emilia - IRCCS Source: ClinicalTrials.gov ↗

Summary

This study aims to use artificial intelligence (AI) to spot and predict problems when medicine is injected for nuclear scans or treatments. It will monitor 1,500 patients to see if the medicine leaks from the vein, which can cause tissue damage and make scan results less accurate. The goal is to create a real-time monitoring system that can alert staff to problems and help correct scan data.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING PET/CT INVESTIGATION OR NUCLEAR MEDICINE THERAPY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda USL IRCCS di Reggio Emilia
RECRUITING

Reggio Emilia, Italy

Contact

Conditions

Explore the condition pages connected to this study.

PATIENTS UNDERGOING PET/CT INVESTIGATION OR NUCLEAR MEDICINE THERAPY